4.7 Article

Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells

Journal

CELL STEM CELL
Volume 2, Issue 2, Pages 151-159

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2008.01.004

Keywords

-

Funding

  1. NCI NIH HHS [R37 CA084198, R37 CA084198-08, R37-CA084198] Funding Source: Medline
  2. NICHD NIH HHS [R01-HD045022, R01 HD045022, R01 HD045022-05] Funding Source: Medline
  3. NIGMS NIH HHS [T32 GM007753] Funding Source: Medline

Ask authors/readers for more resources

Pluripotency can be induced in differentiated murine and human cells by retroviral transduction of Oct4, Sox2, Klf4, and c-Myc. We have devised a reprogramming strategy in which these four transcription factors are expressed from doxycycline (dox)-inducible lentiviral vectors. Using these inducible constructs, we derived induced pluripotent stem (PS) cells from mouse embryonic fibroblasts (MEFs) and found that transgene silencing is a prerequisite for normal cell differentiation. We have analyzed the timing of known pluripotency marker activation during mouse PS cell derivation and observed that alkaline phosphatase (AP) was activated first, followed by stage-specific embryonic antigen 1 (SSEA1). Expression of Nanog and the endogenous Oct4 gene, marking fully reprogrammed cells, was only observed late in the process. Importantly, the virally transduced cDNAs needed to be expressed for at least 12 days in order to generate PS cells. Our results are a step toward understanding some of the molecular events governing epigenetic reprogramming.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available